Cargando…
High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience
The prognosis of patients with Ewing’s sarcoma family of tumors (ESFT) relapse is poor; the 5-year overall survival (OS) is 13%. We evaluated the effectivity of high-dose therapy (HDT) with autologous stem cell transplantation (ASCT) in adult patients with ESFT relapse. Between January 2010 and Janu...
Autores principales: | Paksoy, Nail, Ferhatoglu, Ferhat, Dogan, İzzet, Khanmammadov, Nijat, Iribas Celik, Ayca, Gulbas, Zafer, Başaran, Mert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750591/ https://www.ncbi.nlm.nih.gov/pubmed/36626465 http://dx.doi.org/10.1097/MD.0000000000032213 |
Ejemplares similares
-
Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center
por: Khanmammadov, Nij̇at, et al.
Publicado: (2023) -
Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study
por: Paksoy, Nail, et al.
Publicado: (2023) -
Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study
por: Paksoy, Nail, et al.
Publicado: (2022) -
Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression
por: Dogan, Izzet, et al.
Publicado: (2023) -
Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience
por: Pehlivan, Metin, et al.
Publicado: (2023)